2020
DOI: 10.1016/j.bja.2020.08.011
|View full text |Cite
|
Sign up to set email alerts
|

Pre-procedural screening for COVID-19 with nasopharyngeal polymerase chain reaction testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 7 publications
0
5
0
Order By: Relevance
“…Conversely, in low-risk countries, testing costs and procedural delays outweigh the benefts of screening. In fact, in populations with a low disease prevalence (<2%), RT-PCR screening failed to prove its advantages in clinical practice [23]. In these situations, screening can be more powerful with a symptom questionnaire.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, in low-risk countries, testing costs and procedural delays outweigh the benefts of screening. In fact, in populations with a low disease prevalence (<2%), RT-PCR screening failed to prove its advantages in clinical practice [23]. In these situations, screening can be more powerful with a symptom questionnaire.…”
Section: Discussionmentioning
confidence: 99%
“…[ 10 ] In studies involving a larger sample size, the positive rates were significantly lower (0.5% or lower). [ 11 12 13 ] Up to December 2020, a total of 144 preoperative urology patients were tested using COVID-19 RT-PCR and all patients returned negative results. At present, we do not have data on preoperative screening of surgical patients from all specialities at our hospital or at the national level.…”
Section: Discussionmentioning
confidence: 99%
“…Whether universal pre-procedural testing is effective by itself in reducing risk of COVID-19 spread is controversial, with some arguing that protocols should focus on implementation of appropriate PPE. [2][3][4] COVID testing typically occurs days prior to surgery, utilizing a reverse transcriptase polymerase chain reaction (RT-PCR) nucleic acid amplification test (NAAT) that identifies genetic material present in COVID-19. This is widely considered the most sensitive test.…”
Section: Introductionmentioning
confidence: 99%